FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings ...Middle East

SILVER SPRING, Md., March 30, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it is allowing the use of the Binx Health IO CT/NG Assay at point-of-care settings, such as in physician offices, community-based clinics, urgent care settings, outpatient health care...

Hence then, the article about fda allows for first point of care chlamydia and gonorrhea test to be used in more near patient care settings was published today ( Tuesday 30/03/2021 - 07:02 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings )

Also on site :

• Makeup Artist Alexis Stone’s Jim Carrey Transformation Claim Divides the Internet
• NASDAQ: CRWV: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against CoreWeave, Inc. (CRWV)
• Colorado Buffaloes quarterback Dominiq Ponder dies